J-Pharma Co., Ltd. (TYO:520A)
Japan flag Japan · Delayed Price · Currency is JPY
334.00
-1.00 (-0.30%)
Nov 18, 2026, 10:39 AM JST

J-Pharma Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Operating Income
-3,710-3,710-1,596-1,723
Net Income
-2,466-2,466-1,499-1,652
Earnings Per Share
-195.08-195.08-184.04-263.57
EPS Growth
----

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Net Cash (Debt)
4,4534,4532,3021,073
Net Cash Growth
-93.44%114.49%-
Net Cash Per Share
352.18352.18282.62171.19
Cash & Investments
4,4534,4532,3021,073

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Operating Cash Flow
-2,249-2,249-1,695-1,411
Capital Expenditures
-4.02-4.02-0.19-2.22
Free Cash Flow
-2,253-2,253-1,695-1,414
Free Cash Flow Growth
----

Valuation

Selected indicators aren't available for this stock.